Theriva Biologics Announces Nature Medicine Publication Of Phase 2b VCN-01 Data In Metastatic Pancreatic Cancer
Share
Why It Matters
Theriva published test results for a pancreatic cancer medicine. This shows the company's drug research is moving forward and being shared with doctors.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.